BDBM50194367 4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-(3-methoxyphenyl)-1,4-diazepane-1-carboxamide::CHEMBL220178
SMILES: COc1cccc(NC(=O)N2CCCN(CCCCCNC(=O)\C=C\c3ccc(Cl)c(Cl)c3)CC2)c1
InChI Key: InChIKey=GRSYDSUIMCPQLM-ZRDIBKRKSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glycogen Phosphorylase (PYGL) (Homo sapiens (Human)) | BDBM50194367 (4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-(...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of human liver GPa in presence of glucose | Bioorg Med Chem Lett 16: 5892-6 (2006) Article DOI: 10.1016/j.bmcl.2006.08.055 BindingDB Entry DOI: 10.7270/Q2VD6Z28 | |||||||||||
More data for this Ligand-Target Pair |